GLP-1 Weekly News
Every week we summarise the GLP-1 stories that actually matter — neutrally, with a link to the original source and to our evergreen explainer on each topic. Nothing here is influenced by advertisers.
- July 23, 2026
GLP-1 News — Week of July 6, 2026
A quiet week for GLP-1 news: no new FDA actions, but Lilly updates supply, pricing, and compounding warnings for tirzepatide.
- July 23, 2026
GLP-1 News — Week of July 13, 2026
Tirzepatide supply normalizes, compounding risks rise, and new data sharpen expectations for GLP-1 benefits and long-term use.
- June 7, 2026
GLP-1 News — Week of June 1, 2026
PBM moves reshape GLP-1 access as Cigna cuts coverage and CVS pivots toward multi-drug obesity formularies.